Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Feb-24 4:28 PM View:  | Cara Therapeutics, Inc. (CARA) | 01-Feb-24 | Grant | 13,500 | -- | -- | 9% 153.75K to 167.25K | |
| 27-Jun-23 4:08 PM View: | Cara Therapeutics, Inc. (CARA) | 23-Jun-23 | Sale (Planned) | 2,993 | $3.51 | $10,505.40 | (2%) 156.74K to 153.75K | |
| 06-Apr-23 5:12 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Apr-23 | Sale (Planned) | 2,733 | $4.91 | $13,419.00 | (2%) 159.47K to 156.74K | |
| 07-Mar-23 4:46 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Mar-23 | Sale (Planned) | 6,802 | $9.71 | $66,047.40 | (4%) 166.28K to 159.47K | |
| 23-Dec-22 4:54 PM View: | Cara Therapeutics, Inc. (CARA) | 21-Dec-22 | Market Sale (Planned) | 3,506 | $11.27 | $39,512.60 | (2%) 169.78K to 166.28K | (8%) |
| 05-Apr-22 5:49 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Apr-22 | Market Sale (Planned) | 1,784 | $11.91 | $21,247.40 | (1%) 171.56K to 169.78K | (2%) |
| 01-Mar-22 10:00 PM View: | Cara Therapeutics, Inc. (CARA) | 25-Feb-22 | Grant | 20,000 | -- | -- | 13% 153.68K to 173.68K | |
| 01-Mar-22 10:00 PM View: | Cara Therapeutics, Inc. (CARA) | 25-Feb-22 | Sale (Planned) | 2,114 | $10.29 | $21,753.10 | (1%) 173.68K to 171.56K | |
| 21-Dec-21 5:32 PM View: | Cara Therapeutics, Inc. (CARA) | 17-Dec-21 | Grant | 12,607 | -- | -- | 9% 141.07K to 153.68K | |
| 01-Sep-21 6:07 PM View: | Cara Therapeutics, Inc. (CARA) | 30-Aug-21 | Market Sale (Planned) | 3,847 | $14.20 | $54,627.40 | (3%) 144.92K to 141.07K | (11%) |
| 26-Aug-21 6:15 PM View: | Cara Therapeutics, Inc. (CARA) | 24-Aug-21 | Grant | 9,600 | -- | -- | 7% 135.32K to 144.92K | |
| 01-Apr-21 7:49 PM View: | Cara Therapeutics, Inc. (CARA) | 30-Mar-21 | Grant | 16,000 | -- | -- | 13% 119.32K to 135.32K | |
| 08-Mar-21 5:48 PM View: | Cara Therapeutics, Inc. (CARA) | 05-Mar-21 | Market Sale (Planned) | 3,358 | $17.98 | $60,376.80 | (3%) 122.68K to 119.32K | |
| 08-Mar-21 5:48 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Mar-21 | Grant | 10,000 | -- | -- | 9% 112.68K to 122.68K | |
| 25-Feb-21 9:05 PM View: | Cara Therapeutics, Inc. (CARA) | 25-Feb-21 | Market Sale (Planned) | 5,003 | $19.33 | $96,708.00 | (4%) 117.68K to 112.68K | |
| 25-Feb-21 9:05 PM View: | Cara Therapeutics, Inc. (CARA) | 23-Feb-21 | Grant | 8,000 | -- | -- | 7% 109.68K to 117.68K | |
| 30-Dec-20 6:15 PM View: | Cara Therapeutics, Inc. (CARA) | 30-Dec-20 | Market Sale (Planned) | 2,812 | $15.30 | $43,023.60 | (2%) 112.49K to 109.68K | (< 1%) |
| 29-Dec-20 6:44 PM View: | Cara Therapeutics, Inc. (CARA) | 23-Dec-20 | Grant | 8,000 | -- | -- | 8% 104.49K to 112.49K | |
| 21-Apr-20 6:49 PM View: | Cara Therapeutics, Inc. (CARA) | 21-Apr-20 | Market Sale (Planned) | 12,894 | $15.58 | $200,889.00 | (11%) 117.39K to 104.49K | (< 1%) |
| 21-Apr-20 6:49 PM View: | Cara Therapeutics, Inc. (CARA) | 17-Apr-20 | Grant | 37,500 | -- | -- | 47% 79.89K to 117.39K | |
| 26-Feb-20 5:07 PM View: | Cara Therapeutics, Inc. (CARA) | 24-Feb-20 | Grant | 16,000 | -- | -- | 25% 63.89K to 79.89K | |
| 29-Oct-19 8:36 PM View: | Cara Therapeutics, Inc. (CARA) | 25-Oct-19 | Market Sale (Planned) | 4,000 | $19.91 | $79,640.00 | (6%) 67.89K to 63.89K | 21% |
| 22-Oct-19 5:01 PM View: | Cara Therapeutics, Inc. (CARA) | 18-Oct-19 | Market Sale (Planned) | 4,000 | $19.33 | $77,320.00 | (6%) 71.89K to 67.89K | 19% |
| 16-Oct-19 6:26 PM View: | Cara Therapeutics, Inc. (CARA) | 11-Oct-19 | Market Sale (Planned) | 4,000 | $18.70 | $74,800.00 | (5%) 75.89K to 71.89K | 16% |
| 08-Oct-19 4:44 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Oct-19 | Market Sale (Planned) | 4,000 | $19.19 | $76,760.00 | (5%) 79.89K to 75.89K | 18% |
| 05-Sep-19 5:38 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Sep-19 | Market Sale (Planned) | 20,000 | $22.92 | $458,400.00 | (20%) 99.89K to 79.89K | 31% |
| 05-Aug-19 5:33 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Aug-19 | Market Sale (Planned) | 20,000 | $23.24 | $464,800.00 | (17%) 119.89K to 99.89K | 32% |
| 19-Jul-19 5:47 PM View: | Cara Therapeutics, Inc. (CARA) | 17-Jul-19 | Market Sale (Planned) | 8,996 | $27.50 | $247,390.00 | (7%) 128.88K to 119.89K | 43% |
| 03-Jul-19 3:59 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Jul-19 | Market Sale (Planned) | 20,000 | $21.90 | $438,000.00 | (13%) 148.88K to 128.88K | 28% |
| 30-May-19 6:16 PM View: | Cara Therapeutics, Inc. (CARA) | 29-May-19 | Market Sale (Planned) | 11,397 | $21.19 | $241,502.00 | (7%) 160.28K to 148.88K | 26% |
| 30-May-19 6:16 PM View: | Cara Therapeutics, Inc. (CARA) | 28-May-19 | Grant | 37,500 | -- | -- | 31% 122.78K to 160.28K | |
| 14-Mar-19 5:13 PM View: | Cara Therapeutics, Inc. (CARA) | 13-Mar-19 | Market Sale (Planned) | 16,803 | $18.87 | $317,073.00 | (12%) 139.58K to 122.78K | 17% |
| 14-Mar-19 5:13 PM View: | Cara Therapeutics, Inc. (CARA) | 12-Mar-19 | Market Sale (Planned) | 3,197 | $17.50 | $55,947.50 | (2%) 142.78K to 139.58K | 10% |
| 04-Mar-19 5:49 PM View: | Cara Therapeutics, Inc. (CARA) | 28-Feb-19 | Market Sale (Planned) | 1,500 | $17.50 | $26,250.00 | (1%) 144.28K to 142.78K | 10% |
| 27-Feb-19 5:29 PM View: | Cara Therapeutics, Inc. (CARA) | 25-Feb-19 | Market Sale (Planned) | 2,200 | $17.50 | $38,500.00 | (2%) 146.48K to 144.28K | 10% |
| 02-Jan-19 5:56 PM View: | Cara Therapeutics, Inc. (CARA) | 28-Dec-18 | Market Sale (Planned) | 4,300 | $12.53 | $53,879.00 | (3%) 150.78K to 146.48K | (25%) |
| 31-Dec-18 4:18 PM View: | Cara Therapeutics, Inc. (CARA) | 27-Dec-18 | Grant | 11,779 | -- | -- | 8% 139.0K to 150.78K | |
| 06-Dec-18 4:18 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Dec-18 | Market Sale (Planned) | 3,000 | $18.36 | $55,080.00 | (2%) 142.0K to 139.0K | 14% |
| 05-Nov-18 8:25 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Nov-18 | Option Exercise | 40,000 | $2.05 | $82,000.00 | 38% 105.0K to 145.0K | |
| 05-Nov-18 8:25 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Nov-18 | Market Option Sale (Planned) | 3,000 | $18.77 | $56,310.00 | (2%) 145.0K to 142.0K | 16% |
| 03-Oct-18 4:09 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Oct-18 | Market Sale (Planned) | 3,000 | $23.99 | $71,970.00 | (3%) 98.0K to 95.0K | 35% |
| 06-Sep-18 5:33 PM View: | Cara Therapeutics, Inc. (CARA) | 04-Sep-18 | Market Sale (Planned) | 3,000 | $19.81 | $59,430.00 | (3%) 101.0K to 98.0K | 21% |
| 22-Aug-18 5:26 PM View: | Cara Therapeutics, Inc. (CARA) | 20-Aug-18 | Market Sale (Planned) | 3,000 | $18.89 | $56,670.00 | (3%) 104.0K to 101.0K | 17% |
| 05-Nov-18 8:21 PM View: | Cara Therapeutics, Inc. (CARA) | 06-Aug-18 | Option Exercise | 10,000 | $2.25 | $22,500.00 | 10% 104.0K to 114.0K | |
| 05-Jul-18 5:00 PM View: | Cara Therapeutics, Inc. (CARA) | 02-Jul-18 | Market Sale (Planned) | 3,000 | $19.00 | $57,000.00 | (3%) 107.0K to 104.0K | 17% |
| 05-Jun-18 7:15 PM View: | Cara Therapeutics, Inc. (CARA) | 01-Jun-18 | Market Sale (Planned) | 3,000 | $15.49 | $46,470.00 | (3%) 110.0K to 107.0K | (1%) |
| 25-May-18 4:22 PM View: | Cara Therapeutics, Inc. (CARA) | 23-May-18 | Market Sale (Planned) | 9,000 | $15.19 | $136,710.00 | (8%) 119.0K to 110.0K | (3%) |
| 20-Feb-18 4:43 PM View: | Cara Therapeutics, Inc. (CARA) | 15-Feb-18 | Market Sale (Planned) | 3,000 | $15.02 | $45,060.00 | (2%) 122.0K to 119.0K | (5%) |
| 26-Jan-18 5:53 PM View: | Cara Therapeutics, Inc. (CARA) | 24-Jan-18 | Market Sale (Planned) | 15,000 | $15.00 | $225,000.00 | (11%) 137.0K to 122.0K | (5%) |
| 09-Nov-17 4:36 PM View: | Cara Therapeutics, Inc. (CARA) | 07-Nov-17 | Option Exercise | 20,000 | $2.48 | $49,600.00 | 17% 117.0K to 137.0K |